Serum CHIT1 activity is reported to predict endothelial dysfunction in patients with newly diagnosed, untreated and uncomplicated T2D, while plasma YKL-40 is related with insulin resistance [24,25]. Here, CHIT1 is linked to endothelial dysfunction.